Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ARVINAS, INC. (ARVN)

Arvinas Q3 revenue falls to $0.5 million; net loss widens to $53.9 million

Negative Impact 3 of 5 earnings Written later

Arvinas reported third-quarter 2026 results on November 3, 2026. Revenue was $0.5 million, down from $41.9 million a year earlier, and the net loss widened to $53.9 million, or $0.82 per share, from $35.1 million, or $0.48 per share. The company said its cash, cash equivalents, restricted cash, and marketable securities of $558.9 million are sufficient to fund planned operations into the second half of 2028.

Key points

  • Revenue was $0.5 million for the quarter, all from sales-based royalties under the Rigel License Agreement, versus $41.9 million a year earlier.
  • Net loss was $53.9 million, or $0.82 per share, compared with a net loss of $35.1 million, or $0.48 per share, in the prior-year quarter.
  • Cash, cash equivalents, restricted cash, and marketable securities were $558.9 million at September 30, 2026, down from $685.4 million at December 31, 2025.
  • Dosing began in the monotherapy cohort of a Phase 1/2 trial of ARV-6723, and the company expects to share data from three Phase 1 programs in the fourth quarter of 2026 and in 2027.

The filing

CompanyARVINAS, INC. (ARVN)
Form8-K, current report
Filed with the SECNov 3, 2026, 8:09 AM ET
Accession number0001628280-26-069101

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.